Taurolidine attenuates the hemodynamic and respiratory changes associated with endotoxemia

Shock

Volumn 17, Issue 4, 2002, Pages 308-311

  Egan, Bridget M ^a,b   Bouchier Hayes, David J ^a   Condron, Claire ^a   Kelly, Cathal J ^a   Abdih, Hazem ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Inflammation; Lipopolysaccharide (LPS); Lung injury; Ovine; Sepsis; Septic shock; Taurine

Indexed keywords

DRUG DERIVATIVE; ENDOTOXIN; OXYGEN; PEROXIDASE; TAURINE; TAUROLIDINE; THIADIAZINE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BREATHING; DRUG EFFECT; ENDOTOXEMIA; HEMODYNAMICS; INJURY; LUNG; MALE; METABOLISM; PATHOPHYSIOLOGY; SHEEP;

ANIMALS; BLOOD PRESSURE; ENDOTOXEMIA; ENDOTOXINS; HEMODYNAMIC PROCESSES; LUNG; MALE; OXYGEN; PEROXIDASE; RESPIRATION; SHEEP; TAURINE; THIADIAZINES;

EID: 0036547153     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200204000-00012     Document Type: Article

References (32)

1. Frikker MJ, Lynch K, Pontoppidan H, Wilson RD, Rie MA, Zapol WM: The adult respiratory distress syndrome: aetiology, progression and survival. In Artigas A, Lemaire F, Suter PM, Zapol WM (eds): Adult Respiratory Distress Syndrome. New York: Churchill Livingstone, 1992, pp 3-15.
2. Hasegawa N, Husari AW, Hart WT, Raffin TA: Role of the coagulation system in ARDS. Chest 105:268-277, 1994.
3. Tomashefski JF Jr.: Pulmonary pathology of adult respiratory distress syndrome. Clin Chest Med 11:593-619, 1990.
4. Vallance P, Moneada S: Role of endogenous nitric oxide in septic shock. New Horiz 1:77-86, 1993.
5. Schleimer RP, Rutledge BK: Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 143:1278-1282, 1986.
6. Redl H, Dinges HP, Buurman WA, et al.: Expression of endothelial leucocyte adhesion molecule-1 in septic but not traumatic/hypovolaemic shock in the baboon. Am J Pathol 139:461-466, 1991.
7. Benjamin JD, Fareed J, Centgraf KS, Hart AP, Macwilliams PS, Clayton MK, Wolf H, Krus-Elliott KT: Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. Shock 9:274-281, 1998.
8. Olson NC, Kruse-Elliott KT, Dodam JR: Systemic and pulmonary reactions in swine endotoxemia and gram-negative bacteraemia. J Am Vet Med Assoc 200: 1870-1883, 1992.
9. Knight BI, Skellern GG, Smail GA: NMR studies and GC analysis of the anti-bacterial agent, taurolidine. J Pharm Sci 72:705-707, 1983.
10. Carey PD, Feely TM, Monson JRT: Taurolidine increases survival in lethal endotoxemia of jaundice. Ir J Med Sci 157:332-338, 1988.
11. Erb F, Febvay N, Imbenotte M: Structural investigation of a new organic anti-microbial-taurolidine: a spectroscopic study of its stability and equilibria in various solvents. Talanta 29:953-958, 1982.
12. Myers E, Allwood MC: The interaction between taurolin and endotoxin. Microbios Lett 13:141-144, 1980.
13. Huxtable RJ, Sebring LA: Towards a unifying theory for the actions of taurine. TIPS 7:481-485, 1986.
14. Fennessy F, Smith G, Kelly C, Bouchier-Hayes DJ: Taurine restores endothelial-dependent but not independent dysfunction in young cigarette smokers. Br J Surg 85:1582, 1998.
15. Horn KD: Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). QJM 91(4):265-277, 1998.
16. Lynn WA: Anti-endotoxin therapeutic options for the treatment of Sepsis. J Antimicrob Chemother 41(Suppl A):71-80, 1998.
17. Erb F, Febvay N, Imbonette M: Structural investigation of a organic new anti-microbial-taurolidine: a spectroscopic study of its stability and equilibria in various solvents. Talanta 29:953-958, 1982.
18. Fowler AA, Hamman RF, Zerbe GO, Benson K, Hyers TM: Adult respiratory distress syndrome; prognosis after onset. Am Rev Dis 132:472-478, 1985
19. Pepe PE, Potkin DH, Reus DH, Hudson LD, Carrico HA: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124-130, 1982.
20. Rubin DB, Wiener-Kronish JP, Murray J, Green DR, Turner J, Luce JM, et al.: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 86:474-480, 1990.
21. Dwenger A, Pape HC, Bantel C, Schweitzer G, Krumm K, Grotz M, et al.: Ascorbic acid reduces the endotoxin-induced lung injury in awake sheep. Eur J Clin Invest 24:229-235, 1994.
22. Benjamin JD, Fareed J. Centgraf KS, Hart AP, Macwilliams PS, Clayton MK, Wolf H, Krus-Elliott KT: Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model. Shock 9:274-281, 1998.
23. Browne MK, Leslie GB, Pfirrmann RW: Taurolin: a new chemotherapeutic agent. J Appl Bacteriol 41:363-368, 1976.
24. Browne MK, Leslie GB, Pfirrmann RW: The in vitro and in vivo activity of Taurolin against anaerobic pathogenic organisms. Surg Gynaecol Obstet 145: 842-846, 1977.
25. Gormans SP, McCafferty DF, Woolfson AD: Reduced adherence of microorganisms to mucosal epithelial cells following treatment with taurolin: a novel antimicrobial agent. J Appl Bacteriol 62:315-320, 1987.
26. Watson RWG, Redmond HP, Bouchier-Hayes D: Taurine upregulates antimicrobial function of human inflammatory cells through a calcium dependent mechanism. Surg Forum XLV:679-681, 1994.
27. Hickey MJ, Issekutz PH, Reinhardt PH, Fedorak RN, Kubes P: Endogenous interleukin-10 regulates hemodynamic parameters, leucocyte-endothelial cell interactions, and microvascular permability during endotoxemia. Cir Res 83: 1124-1131, 1998.
28. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57, 1992.
29. Schuller LG, Quinn MR, Wright C, Park E: Taurine protects against oxidant induced lung injury: possible mechanisms of action. Adv Exp Med Biol 359:31, 1994.
30. Park E, Schuller LG, Quinn MR: Taurine chloramine inhibits production of Nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translationalevents. J Immunol 154:4778-4784, 1995.
31. Christenson JT, Owunwanne A: Leucocyte sequestation in endotoxemia and the effect of low molecular weight dextran. Eur J Nucl Med 17:28-33, 1990.
32. Opal SM, Yu RL Jr.: Anti-endotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions. Drugs 55:497-508, 1998.